The influence of danazol on pituitary function and on the ovarian follicular hormone secretion in premenopausal women

References

• Andrews M. C., Wentz A. C. The effects of danazol on gonadotropins and steroid blood levels in normal and an-ovulatory women. Am J Obstet Gynecol 1975; 121: 817
   PubMed Web of Science ®Google Scholar
• Barbieri R. L., Ryan K J. Danazol endocrine pharmacology and therapeutic applications. Am J Obstet Gynecol 1981; 141: 453
   PubMed Web of Science ®Google Scholar
• Barbieri R. L., Evans S., Kistner R. W. Danazol in the treatment of endometriosis: analysis of 100 cases with a 4-year follow up. Fertil Steril 1982; 37: 737
   PubMed Web of Science ®Google Scholar
• Bohnet H., Hanker J. P., Schweppe K. W., Schneider H. P. G. Changes of prolactin secretion following long-term danazol application. Fertil Steril 1981; 36: 725
   Google Scholar
• Braun P., Wildt L., Leyendecker G. The effect of danazol on gonadotropin secretion during the follicular phase of the menstrual cycle. Fertil Sterile 1983; 40: 37
   Google Scholar
• Carlström K., Döberl A., Rannevik G. Peripheral androgen levels in danazol-treated premenopausal women. Fertil Steril 1983; 39: 499
   PubMed Web of Science ®Google Scholar
• Carlström K., Döberl A., Gershagen S., Rannevik G. Peripheral levels of dehydroepiandrosterone sulfate, dehydroepiandrosterone, androstenedione, and testosterone following different doses of danazol. Acta Obstet Gynecol Scand 1984, Suppl. 123: 125
   Google Scholar
• Chimbira T. H., Andersen A. B. M., Cope E., Turnbull A. C. Effect of danazol on serum gonadotropins and steroid hormone concentrations in women with menorrhagia. Brit J Obstet Gynaecol 1980; 87: 330
   Google Scholar
• Dhont M., Delbeke L., van Eyck J., Voorhoof L. Danazol treatment of chronic mastopathy: a clinical and hormonal evaluation. Postgrad Med J 1979; 55(suppl. 5)66
   Google Scholar
• Dmowski W. P., Headly S., Radwanska E. Effects of danazol on pulsatile gonadotropin patterns and on serum estradiol levels in normally cycling women. Fertil Steril 1983; 39: 49
   PubMed Web of Science ®Google Scholar
• Dymling J F., Jeppsson S., Rannevik G. Effect of danazol on thyroid function in postmenopausal women. Acta Obstet Gynecol Scand 1984, Suppl. 123: 137
   Google Scholar
• Döberl A., Jeppsson S., Rannevik G. Effect of danazol on serum concentrations of pituitary gonadotropins in postmenopausal women. Acta Obstet Gynecol Scand 1984, Suppl. 123: 95
   Google Scholar
• Franchimont P., Cramilion C. The effect of danazol on anterior pituitary function. Fertil Steril 1977; 28: 814
   Google Scholar
• Fraser I. S., Thorburn G. D. Effects of danazol on pituitary gonadotropins in post-menopausal women. Aust N Z J Obstet Gynaecol 1978; 18: 247
   Google Scholar
• Fraser I. S., Markham R., McIlveen J., Robinson M. Dynamic tests of hypothalamic and pituitary function in women treated with danazol. Fertil Steril 1982; 37: 484
   Google Scholar
• Jenkin G. Review: The mechanism of action of danazol, a novel steroid derivative. Aust N Z J Obstet Gynaecol 1980; 20: 113
   Google Scholar
• Lauersen N. H., Wilson K. H. The effect of danazol treatment of chronic mastitis. Obstet Gynaecol 1976; 48: 93
   Google Scholar
• Lauersen N. H., Wilson K. H. Evaluation of danazol as an oral contraceptive. Obstet Gynecol 1977; 50: 91
   Google Scholar
• Lieberman B. A., Thom S., Murray M. A. F., Jacobs H. S. Selective inhibition by danazol of follicle-stimulating hormone during the luteal phase. Br J Obstet Gynaecol 1977; 84: 55
   Google Scholar
• Lucky A. W., Rich B. H., Rosenfield R. L., Fung K. S., Roche-Bender N. LH bioactivity increases more than immuno-reactivity during puberty. J Pediatr 1980; 97: 305
   Google Scholar
• Luciano A. A., Hauser K. S., Chapler F. K., Sherman B. M. Danazol: Endocrine consequences in healthy women. Am J Obstet Gynecol 1981; 141: 723
   Google Scholar
• Meldrum D. R., Pardridge W. M., Karow W. G., Rivier J., Vale W., Judd H. L. Hormonal effects of danazol and medical oophorectomy in endometriosis. Obstet Gynecol 1983; 62: 480
   Google Scholar
• Peters F., Reck G., Zimmermann G., Breckwoldt M. The effect of danazol on the pituitary function, thyroid function, and mastodynia. Arch Gynecol 1980; 230: 3
   Google Scholar
• Rannevik G., Jeppsson S., Kullander S., Thorell J. Effects of synthetic luteinizing hormone-releasing hormone on plasma luteinizing hormone and follicle-stimulating hormone in amenorrheic women. Fertil Steril 1974; 25: 547
   Google Scholar
• Rannevik G. Hormonal, metabolic and clinical effects of danazol in the treatment of endometriosis. Postgrad Med J 1979; 55(suppl. 5)14
   Google Scholar
• Rönnberg L., Ylöstalo P., Jörvinen P. A. Effects of danazol in the treatment of endometriosis. Postgrad Med J 1979; 55(suppl. 5)21
   Google Scholar
• Thorell J. I., Holmström B. Production of antisera against highly purified human follicle-stimulating hormone, luteinizing hormone and thyroid-stimulating hormone. J Endocrinol 1976; 70: 1
   Google Scholar
• Thorell J. I., Larson S. M. Radioimmunoassay and Related Techniques. C. V. Mosby Company, St Louis 1978
   Google Scholar
• Thorell J. I., Dymling J F., Rannevik G. Effect of danazol on thyroid function in women. Postgrad Med J 1979; 55(suppl. 5)33
   Google Scholar
• Wide L. Male and female forms of human follicle-stimulating hormone in serum. J Clin Endocrinol Metab 1981; 55: 682
   Google Scholar
• Wood G. P., Wu C. H., Flickinger G. L., Mikhail G. Hormonal changes associated with danazol therapy. Obstet Gynecol 1975; 45: 302
   Google Scholar